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ABSTRACT  
 
In 2011, a new and innovative collaborative program was established in Spain 
between the Autonomous Community of La Rioja and the Autonomous Community of 
the Basque Country in the matter of kidney transplant coordination, with the objective of 
increasing the number of kidney donors and the access of patients to kidneys for 
transplantation through a shared waiting list and a joint organization. Seven years after 
the foundation of the program, La Rioja had already transplanted 100 kidneys, and an 
analysis was carried out to assess its efficacy as well as some possible points for 
improvement. 
To do so, data from all patients and donors involved in the 100 procedures were 
collected and examined, looking for possible indicators and reasons for the failure or 
success of each transplantation as a function of certain variables, such as the region 
were the kidneys were extracted or the distance and time that the organ had to travel 
before being implanted into the recipient.  
It could be obtained from the achieved results that there were no significant 
differences in the outcomes of the patients based on the regions of origin of the kidneys, 
but a significant correlation was found between glomerular filtration rates (GFR) at the 
time of hospital discharge and the number of hours that the organs remained stored until 
being transplanted into the receptor. 
After analyzing whether conditions of storage could affect somehow the overall 
function of the kidneys, it was concluded that the organ cooling mechanism during the 
process should be further controlled; the amount of time and conditions in which the 
organs remained stored affected their overall functionality at the date of hospital 
discharge, so La Rioja needs to concentrate on reducing such time in future procedures 
and improving the storage conditions of kidneys to provide better outcomes for their 
patients. 
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1. INTRODUCTION 
 
The Spanish National Transplant Organization (in Spanish, Organización 
Nacional de Trasplantes, ONT) was first created in 1989. Since 1992, Spain has become 
the world leader in organ donation and transplantation rates for 26 consecutive years, 
and donation rates as of 2017 have reached 47 pmp. This value corresponds to 19.2% 
all donations obtained in the European Union and 6.4% worldwide. Moreover, Spanish 
transplantation rates have also remained on top for the last two decades, reaching 113.4 
transplants pmp in 2018 -a number significantly superior to the average of the European 
Union, at 66.9 pmp-. [1] 
 
 These outstanding results have been accomplished thanks to the introduction in 
1989 of a new model, referred to as the “Spanish Model”, and that has not only been 
carried out in our country, but also abroad in nations such as Portugal and Croatia, and 
with exceptional outcomes as well.  
 
 
 
Fig. 1.1 World average distribution of deceased organ donors per million population [40] 
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Spain went from having 14 donors pmp in 1989 to the achieve current extraordinary 
rates and lead world rankings, and to understand this tremendous increase it is therefore 
essential to comprehend what the role of the Spanish National Transplant Organization 
has been, and the changes that have been caused by the implementation of the so-
called ‘Spanish model’. 
 
 
2. THE SPANISH MODEL AND THE NATIONAL 
TRANSPLANT ORGANIZATION 
 
Immediately after its creation, the initial objective of the ONT was to establish an 
appropriate legal, economic, ethical, medical and political framework oriented to 
improving organ donation, and then put in place an efficient system to organize and 
coordinate all steps involved in the transplantation process.  
 
To do this, the ONT introduced a network of transplant coordinators at three 
differentiated levels: national, regional and hospital. All of them were required to be 
medical doctors – generally intensive care doctors-, and worked in close contact with 
each other to ensure the optimal completion and tracking of all the transplantation 
process. Moreover, an enormous effort was carried out to develop general and 
specialized training programs, to ensure their preparation for all essential activities 
involved in their work, such as detection of possible donors, family interviews or other 
management duties, as well as participation in media (radio, TV, …) to increase people’s 
awareness about donation and the role of the ONT. [2] 
 
The Spanish National Transplant Organization positioned itself as a service 
agency, in charge of the logistics involved in organ distribution, management of waiting 
lists, data analysis, basic statistics and storage and any other action that can contribute 
to improving the donation and transplantation procedure and ensuring the quality of the 
program.  
 
The presence of coordinators became a key aspect in the program -without 
disregarding the importance of the other implemented measures-, and has been proven 
throughout the years to be a determinant factor for its outcome, especially when 
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compared to programs developed in other nations. The reason is that coordinators 
oversee a plethora of crucial aspects of the process.  
 
Coordinators have the ultimate goal of facilitating the possibility of donation and 
obtaining the maximum number of good quality organs for transplantation, without 
leaving any detail subjected to improvisation, and always following rigorously all medical, 
legal and ethical codes. To do so, and before any donor appears, they must be able to 
efficiently detect and monitor possible donors, as well as prepare all necessary logistics 
both outside and inside the hospital, to be ready in case organs become available for 
transplantation. If so, they also need to verify the optimal state of all organs involved. [3] 
 
When a donor is found, they request the family consent for donation, and 
supervise the legal certification of the dead body, including the reconstruction of the 
person’s visual appearance after the surgical procedure. Afterwards, they guarantee the 
correct packaging and transport of all organs involved, and on top of all that, they also 
need to supervise administrative activities, the correct management of resources 
(economic, legal, ethical, media), training programs, and the quality, safety and 
transparency of the practice. [4] 
 
The transplantation process can be regarded as a great example of teamwork, 
as it is the activity that involves the greater percentage of hospital professionals. The role 
of the coordinator is therefore to lead the team, and make sure each member is ready to 
act appropriately at any given time or circumstance. Differences in donation and 
transplantation rates between regions in our country are sometimes explained by 
changes of coordinators, which underlines their importance in the success of the Spanish 
model.  
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3. RENAL TRANSPLANT 
 
The first case of success in kidney transplantation brings us back to 1954, when 
a team lead by John Merrill and Joseph Murray, Nobel prize laureates in 1991, was able 
to implant in a 23-year-old the organ coming from his twin brother –so that rejection 
would be minimized-.  Before that, some failed procedures were carried out that resulted 
in acute rejection, such as the one that took place in Ukraine in 1933 lead by the surgeon 
Dr. Voronoy. Advancements in the understanding of compatibility issues and 
development in medications such as cyclosporine allowed more control of rejection, 
leading to further prosperous surgeries. [5] 
 
In Spain, the first renal transplants were possible in 1965, in Barcelona’s Clinic 
Hospital and Madrid’s Fundación Jiménez Diaz. In 2017, a total number of 135,860 
transplants were executed worldwide -a 7.2% increase with respect to the previous year, 
- among those 89,823 correspond to kidney transplantations, and 3,269 were made in 
Spain-. [6] 
 
3.1 Types of donors 
The Spanish legislation considers someone as possible donor if he or she has 
not expressed direct opposition to the organ extraction procedure while alive.  
There are two main types of donors: living and deceased, and among deceased 
donors we can differentiate two subtypes: heart beating deceased donors and donors 
after circulatory death (DCD). 
Living renal donors are people who altruistically, and meeting all corresponding 
regulations, decide to give one of their kidney to someone in need. They must meet all 
legal requirements and clinical procedures, without coercion or economical 
remuneration, independently of being related or not to the patient, although it usually 
involves close family members. 
On the other hand, deceased donors are individuals who have passed away 
because of an irreversible brain injury that completely stops their brain activity (heart 
beating deceased donors) or that have suffered of asystole, that is, their heart has 
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stopped beating (DCD). Asystole can have more direct implications in the state of the 
kidneys, as the heart is the responsible of permanently perfuse the organs, and any 
cease of its activities can result in organ damage. This is why it is only acceptable in 
specific circumstances. [7] Since, we can differentiate four different categories of 
possible DCD, which were first defined in the 1995 Maastricht Conference. [8]  
Currently in Spain the classification used is the “Modified Maastricht 
Classification”, stablished in Madrid in 2011 [9]: 
 
I. Victims of a sudden death outside the hospital setting and that have not 
received any resuscitation maneuvers.  
II. People who have suffered a cardiac arrest, in or outside a hospital setting, 
and have received resuscitation maneuvers without success.  
III. Individuals that have been clinically diagnosed to suffer from cardiac 
death shortly, and are withdrawn of life-sustaining therapies.  
IV. Individuals with brain death who experience a cardiac stop just before 
being moved to the surgical room for the organ extraction.  
 
Advancements in transplant coordination have helped introduced this type of 
donation, which requires higher levels of organization. Until 1999 individuals suffering 
from asystole were not considered as possible donors in Spain, as it was in that year 
that type II asystole started to be permitted in our country. However, it was not until 2012 
that type II asystole could be implemented. This has allowed donation rates to increase 
even more during these last years. 
Every year more donors from asystole and brain death appear, and this is not 
only because people become more altruistic regarding organ donation, but because 
organization and coordination have improved so much that it is nowadays possible to 
detect donors and obtain more organs in a much more efficient way. The introduction of 
asystole donors is a clear example of this success, and it can be shown for example with 
the fact that a significant number of donors from previous years used to appear after car 
accidents and crashes, and, even if the number of car accidents and death has 
significantly decreased over the last years, the number of heart beating deceased donors 
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has not decreased. [10] 
 
 
Although there are no actual age limits for donation, recommendations state that 
donors should be 75-years-old or less, and without clinical history of any renal disease. 
For asystole, the recommended maximum considered age is 50. However, general 
health condition is an essential aspect, as it is always possible to find 30-years-old 
donors in worst health condition than some of 70 or older. For that reason, it is important 
to assess possible donors in an individual manner, to confirm that there are no other 
health conditions that can affect the final state of the organ. [11] 
3.2 Hospitals with neurosurgical activities  
There is an important difference as well between hospitals that perform 
neurosurgeries and those that do not in terms of number of donors. In hospitals that do 
have a neurosurgery unit, there are more patients with neurological injury that require 
critical care, and therefore more donors from brain death because of complications 
during the surgical procedures.  
In the year 1999, the Spanish National Transplant Organization started a program 
to ensure the optimal quality of all the activities. This program started by analyzing the 
total number of deaths that occurred in the Intensive Care Unit (ICU), and among those, 
the number of brain deaths. The ultimate objective of the analysis was to estimate the 
number of donors that a certain hospital should have in function of other variables such 
as their number of beds. 85% of all hospital with transplantation extraction activities 
 
Brain death Rate pmp Asystole 
Fig. 3.1 Evolution of each type of donation in Spain from 1989 to 2014 
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participated in the analysis, and the examined data showed that 13% of all deaths in 
hospitals with neurosurgical activities were brain deaths – and possible donors-, whereas 
this percentage lowered to 5% for hospitals that did not had such activities. Currently in 
Spain, approximately 55% of all hospitals with extraction capabilities have neurosurgical 
units. [12] 
 
3.3 Surgical procedure, possible complications and packaging 
The surgical and packaging procedures are now standardized and a common 
kidney extraction consists of many different steps, among which we can distinguish the 
exsanguination (with or without cannulation), clamping, the introduction of heparin to 
avoid coagulation, perfusion, preservation liquid to maintain kidney’s function and 
structure and extraction. Although the steps are general indications, the degree of 
expertise of each surgeon can largely affect the overall result of the extraction. Thus, 
some complications can take place, including arterial or venous thrombosis and stenosis. 
Regarding possible complications after the extraction, there are three main 
phases in which the removed kidney could suffer important damage. The first one is 
called warm ischemia time, and refers to the amount of time that passes between the 
interruption of blood circulation across the organ and its perfusion with a hypothermal 
preservation solution. The second one is the cold ischemia time, considered as the time 
between the storage of the organ and its eventual transplant in the receptor. During this 
cold ischemia time, kidneys are stored in a fridge under hypothermal conditions and with 
preservation liquids to minimize the energy requirements of the organ. In order to reduce 
the energy consumption and lessen damage to the kidney, the organ should be stored 
at a temperature of around 4ºC, but not much less because it could freeze and become 
unusable as a result. [13] 
This is achieved by storing the kidneys in different containers and fridges, to 
ensure the maintenance of appropriate hypothermal conditions. Each kidney is placed in 
a sterilized and isolated bag containing preservation liquid. Each bag is then placed 
inside an opaque container called Duchess (in Spanish, ‘Duquesa’), which is filled with 
a saline solution at a temperature of 5ºC. The Duchess is subsequently placed in another 
sealed bag, and the ensemble is introduced, in a vertical position and surrounded by ice, 
inside a portable fridge. [14] 
Keeping the kidney cold at 4-5ºC allows it to be optimally stored for a maximum 
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period of around 24 hours before implantation. However, this could also have adverse 
effects, as it can provoke cellular edema (undesirable excessive fluid volumes 
accumulated in the circulatory system or interstitial spaces), and accumulation of toxic 
metabolites.  
The third process that can seriously damage the organ is the re-perfusion, once 
the kidney is implanted and blood circulation is re-established. Blood flux could then 
provide oxygen but also remove toxic metabolites, which could in turn damage other 
tissues.  
 
 
 
 
 
 
 
 
 
Because the locations of donors and receptors of an organ are not always near, 
kidneys need to be perfectly stored to ensure that, no matter what the destination is, they 
are impeccable both functionally and structurally. Even though in general the transplant 
is performed in the same autonomous community where the extraction took place, that 
can still involve big transport hours in large regions– such as Andalucía-; also, the organs 
could only be found compatible with patients from other regions.  
In the specific case of La Rioja, this situation is even more present, as the novel 
program requires the continuous transport of organs to and from the Basque Country. 
This is the reason why appropriate monitorization and surveillance of both cold ischemia 
time and temperature inside the fridge should be carried out.   
 
Preservation liquid 
B
ag
 
B
ag
 
‘Duchess’ 
 
Fridge 
Saline solution 
Fig. 3.2 Diagram representing how kidneys are stored 
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3.4 Monitoring after transplantation. Indicators of optimal organ function and 
condition 
The monitoring of transplanted organs can be differentiated into two main stages. 
The first one corresponds to the supervising of the first two months after the surgery 
(short-term) and the other corresponds to the long-term surveillance. 
The short-term monitoring can be divided as well into other three periods: the first 
day, days 2 to 8 and days 9 to 60 after the transplant. The first day, the patients need to 
be evaluated immediately after leaving the operating room, to check hemodynamic and 
ventilatory stability and ensure that all immunosuppression protocols have been 
implemented. In addition, it is important to see whether the patient presents any 
hemorrhage and, of course, the state of the urine output. During the first week, the patient 
usually improves its general condition and renal function begins to become more stable. 
The treatment that he or she must receive is dependent on the state of the transplanted 
kidney, as these usually show an excellent, slow or retarded function. In this case, urine 
output is used as a reliable indicator of such function, and more specifically, the serum 
creatinine levels are observed. [11] 
So, given that the most important indicators taken into consideration are the 
creatinine levels and the volume of urine output, a classification can be established, as 
the patients with excellent organ function have a rapid decrease in serum creatinine 
levels and no dialysis is required, whereas those with slow function have a slow decrease 
in serum creatinine levels and no dialysis required, and the ones with retarded function 
usually need dialysis and present oliguria. In the latter cases, it could be useful to obtain 
some images to exclude the possibility of having urine leaks and obstructions.  
In all cases, rejection of the graft is an important factor to consider, and can occur 
immediately after the transplant or some days after. The rejection takes place because 
of the action of antibodies against donor human leukocyte antigens, recognized as 
foreign. It is anticipated before, by histocompatibility analysis and in order to recognize if 
a certain organ is suitable for the patient, and after the procedure, with 
immunosuppressive treatment; however, there could be situations where it could 
happen, so it cannot be disregarded. [15] 
After the start of the second week, the patients begin or not to be discharged, 
depending on their condition and some external issues that need to be evaluated as well, 
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such as distance from their homes to the hospital in case of an emergency. Patients are 
appropriately informed before leaving the hospital facilities of their treatment and 
condition, and are expected to continue with the indicated medication and diet. Also, they 
are informed of the possible implications and risks if they fail to follow the advice given.  
Lastly, a long-term evaluation needs to be carried out. In the case of the 
Transplant Coordination Unit of the San Pedro Hospital of La Rioja, where this project 
was developed, the patients were evaluated six months after the surgery, and then every 
year after it. In this period, blood tests and checkups are performed, to analyze the 
presence of any abnormalities. The immunosuppression can have negative effects in the 
long term leading to further prevalence of infections, so it is important to review 
periodically the condition of the transplanted individuals. [16] 
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4. THE AUTONOMOUS COMMUNITY OF LA RIOJA. THE 
COOPERATION AGREEMENT WITH THE BASQUE 
COUNTRY 
4.1 The Autonomous Community of La Rioja 
 
The Autonomous Community and province of La Rioja is a region located in the 
North of Spain and surrounded by the Basque Country, Aragon, Navarra and Castile and 
León. Its total population in 2016 was of about 315,794 people, according to the Spanish 
National Statistics Institute, becoming the smallest region of Spain in terms of population 
and one of the smallest in terms of total surface in kilometers squared. [17] 
La Rioja has only one public hospital endorsed to extract and transplant organs, 
the San Pedro Hospital in Logroño, La Rioja’s capital, which extracts and transplants 
kidneys and livers, and has no neurosurgical unit nor activities. It is composed of 630 
beds and has 14 available operating rooms.  The Transplant Coordination Unit of La 
Rioja, lead by Dr. Fernando Martínez Soba, is located close to the Intensive Care Unit 
of such hospital. [18] 
 
Despite being such a small region and with limited resources, La Rioja has 
become a reference in terms of organ transplant coordination. In 2017, La Rioja was 
ranked second in kidney donation rates with 71 per million population, and that same 
year, the average age of donors in La Rioja was 70.7, becoming the region with the 
oldest donors in Spain. [19] 
 
Ever since 2006, La Rioja has participated in collaborative projects with the 
Spanish National Transplant Organization in national and international training 
programs.  
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4.2 Renal Transplant Cooperation Agreement between La Rioja and the Basque 
Country 
 
Before the year 1995, all renal transplants involving patients from La Rioja were 
performed in either Zaragoza or Pamplona. However, since the year 1995 a collaboration 
 
Fig. 4.1 Organ donations in Spain in 2017 per million population [19] 
Fig. 4.2 Average Spanish donor age per Autonomous Community in 2017 
(national average was 60.4 years) [19] 
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agreement with the Basque Country (which was officially approved in 1996 in the 
Congress of Deputies) made it possible for people from La Rioja to be transplanted in 
Barakaldo’s Cruces Hospital. This agreement, always supervised by a monitoring 
commission, lasted for 15 years, until La Rioja received official sanitary permission to 
carry out renal transplantation procedures in the San Pedro Hospital of Logroño. 
 
Nonetheless, the process to obtain such permission was complicated, mainly 
because of national and regional regulatory issues. To begin with, in order to obtain it La 
Rioja needed legal approval from its own Regional Health Department, and all sanitary 
authorizations had to follow the legal requisites given by the 2070/1999 Royal Decree 
that was applicable at that moment. [20] To fulfil those, in the year 2007 the San Pedro 
Hospital started a training program to prepare professionals that would be involved in 
transplantation procedures and equipped its facilities with histocompatibility and 
pathological anatomy laboratories. 
 
Yet, not only there were legal requirements to follow, but also compulsory 
guidelines validated and accepted by all autonomous communities through the National 
Transplant Committee, in charge of establishing the criteria for organ distribution. 
 
  Before 2011, these criteria specified that the organs had to be first offered to 
donors located in the same hospital where they were extracted, then to near hospitals in 
the region or autonomous community and finally to the adjoining autonomous 
communities. La Rioja wanted to maintain the collaboration agreement with the Basque 
Country, and for that purpose they had to suggest changing such criteria, so that their 
kidneys could be offered directly to the Basque Country. These changes in distribution 
norms were eventually approved in 2010, and led to the writing of a new agreement with 
law status between the Basque Country and La Rioja, signed in 2011. [21] 
 
Through this agreement both regions agreed to share a common waiting list, so 
all kidneys coming from La Rioja and the Basque Country would be offered in a shared 
database, and after La Rioja had already been granted permission for implantation 
activities, they could be transplanted in either autonomous community. 
 
  All these documents were signed right in the middle of an economic crisis, and 
some political and social sectors began to question the affordability of the program due 
to its high cost. In 2012, the Spanish National Government pressured the National 
Transplant Organization to find ways to cut costs and regulate the number of authorized 
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transplantation centers. To do so, the National Transplant Organization released a report 
analyzing certain epidemiologic variables, with a conclusion stating the recommendation 
of having one transplantation center for every 1.5 million population, and carrying out in 
each of them a minimum of 40 transplants per year, unless a lower activity could be 
justified because of geographical reasons. [22] 
 
 A planning criteria for all Spanish transplant programs was released in December 
2012, specifying recommendations based on activities and population. La Rioja, 
because of being the smallest autonomous community in terms of population and 
performing a low number of surgical procedures, did not satisfy any of the two conditions; 
nevertheless, its program could continue as it was understood that there was a 
geographical criterion of enough importance for the activities to be resumed.  
  
In 2013, the agreement between La Rioja and the Basque Country was further 
extended, including a shared waiting list not only for adults but also for children and living 
adult kidney transplants. In addition, it was decided in such document that the urgent 
neurosurgery service of La Rioja would be provided by the one from the Santiago Apostol 
Hospital in Vitoria.  
 
As of 2018 the program is still successfully underway, with both La Rioja and the 
Basque Country occupying the top positions in terms of renal donation and 
transplantation rates in Spain. In addition, it has allowed both regions to reduce the 
overall waiting list, below the national average. [23] 
 
In September of that same year La Rioja completed its 100th transplant since the 
beginning of the joint program.  
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5. DATA. DEFINITIONS 
 
100 kidney transplants were carried out in La Rioja since 2011 as part of the 
cooperation agreement with the Basque Country. Therefore, the information available 
corresponds to each of the recipients and the donors from those 100 procedures.  
 
The total number of variables extracted for the donors and for the recipients are 
defined as follows:  
 
5.1 Donor data 
 
 A donor can be referred as a person who, willingly or with family´s consent after 
passing away, donates an organ that is eventually transplanted. The person can donate 
organs while still alive (living donor) or after death (deceased donor). In the case of the 
data that was obtained for the elaboration of this project, it is important to note that there 
were only deceased donors.  
 
 5.1.1 Age: time the donor lived until the organ/s were extracted. In the data, this 
variable is expressed in years. 
 
 5.1.2 Sex: biological distinction of humans into two categories, male and female. 
 
 5.1.3 Blood type: description of the donor type of blood. There are four main 
groups for the ABO system (A, B, AB and O), which differ in the presence of antigens on 
red blood cells and the antibodies present in plasma. Additionally, the Rh system adds 
a positive or negative symbol to the ABO system, depending on the presence or not of 
the Rh antigen on red blood cells. This results in eight possible combinations: A+, A-, 
B+, B-, AB+, AB-, O+, O-. 
 
 5.1.4 Hypertension: the blood pressure is the force that blood exerts over arterial 
vessel walls as it is pumped by the heart. The measurement is composed of two values, 
one referring to the systolic (in the moment of a heart beat) pressure and another 
referring to diastolic (at relaxation). Ideal blood pressure falls in the range of 90/60 to 
120/80 mmHg. In the data, a person is categorized as hypertensive if the value of systolic 
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blood pressure is superior or equal to 140 mmHg and/or the diastolic pressure is superior 
or equal to 90 mmHg.  
 
 5.1.5 Diabetes mellitus: disease caused by the inability of the body cells to 
correctly absorb glucose from the bloodstream. There are two types of diabetes mellitus: 
type I, in which the body is unable to produce the required amount of insulin (a hormone 
produced in the pancreas that regulates glucose levels in blood), and type II, in which 
there is not a lack in production of insulin, but there is a resistance to it, so glucose cannot 
be correctly absorbed and its concentration in blood increases. In the obtained data, 
people are simply categorized as diabetic or non-diabetic, without making any 
distinctions between type I and type II diabetes.  
 
 5.1.6 Body mass index: defined as donor body mass (expressed in Kg) over 
height (expressed in meters) squared.  
 
 5.1.7 Donor type: donors can be living or deceased. Given that all donors from 
the program were deceased, the distinction made is whether this occurred after brain 
death or circulatory death (DCD). In the region of La Rioja, only type II and type III DCD 
are considered.  
 
 5.1.8 Serum creatinine: waste product produced from creatine degradation. It is 
present in blood and excreted through urine after kidney filtration. It is usually measured 
in a concentration of milligrams over deciliters (mg/dL). A normal creatinine concentration 
range for an adult male individual is between 0.7 and 1.3 mg/dL, while a normal range 
for an adult female is between 0.5 and 1.2 mg/dL. An increase in creatinine concentration 
in blood (and therefore, decrease in glomerular filtration rate) can indicate kidney failure, 
which is the reason why this variable, calculated with blood extraction analysis, is 
extensively used to determine the state of the donor kidneys. [24] 
 
 5.1.9 Glomerular filtration rate (GFR): estimation of the amount of fluid that is 
filtered from the glomeruli to the Bowman capsule in a nephron (functional unit of the 
kidney) per minute. It is used to estimate the functional state of kidneys to be donated. 
The threshold for normal renal functioning is usually established at 60 mL/min, although 
GFR is calculated taking into account different variables, such as age, sex or race, so 
the optimal value can vary depending on those. In this project, the calculation of GFR is 
made using the CKD-EPI (Chronic Disease Epidemiology Collaboration) equation [25]: 
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5.1.10 Hepatitis C virus: virus responsible of liver inflammation. It can also have 
negative effects on kidneys, so it was important to check if the donor is a carrier of the 
virus to assess the state of his or her kidneys. None of the donors participating in the 
program had the virus.  
 
5.1.11 Hospital of origin: the hospital in which the donor organs were extracted. 
Since the program is based on a close collaboration between La Rioja and Basque 
Country, the majority of organs were originated in those regions. In La Rioja, the main 
hospital is the San Pedro Hospital, located in Logroño, while in Basque Country the 
principal ones are located in Vitoria, Bilbao and San Sebastián. Other hospitals that 
generated kidneys that participated in the program are in Galdakao, Madrid, Catalonia, 
Asturias or Navarra. If a region produces an organ in a certain location and a compatible 
recipient cannot be found in that region, the organ is offered to other ones. That is the 
reason why some of the organs that participated in the analysis came from outside the 
collaborating regions. 
       
5.2 Recipient data 
 
A recipient is a person who gets transplanted an organ (in this case a kidney) 
coming from a donor. The recipient is first diagnosed with a chronic renal disease and is 
included in a waiting list. Since a malfunctioning kidney cannot appropriately filter toxic 
products present in blood, the person has to undergo dialysis (artificial filtration) until a 
suitable donor is available. In order to determine suitability, several factors are taken into 
account, and among those it is of tremendous importance the human antigen leukocyte 
(HLA) match between the donor and recipient. All recipients from the program were 
residents of municipalities in La Rioja. 
 
CDK-EPI equation for GFR estimation  
𝐺𝐹𝑅 = 141 ×  min ൬
𝐶𝑟𝑒𝑎𝑡
𝑘
, 1൰
𝑎
× max ൬
𝐶𝑟𝑒𝑎𝑡
𝑘
, 1൰
−1.209
×  0.993𝐴𝑔𝑒
×  1.018ሾ𝑖𝑓 𝑓𝑒𝑚𝑎𝑙𝑒ሿ ×  1.159 ሾ𝑖𝑓 𝑏𝑙𝑎𝑐𝑘ሿ 
    
Where: Creat = Creatinine [mg/dL]  
  k = 0.7 if female; k = 0.9 if male 
  a = -0.329 if female; a = -0.411 if male 
 
(5.1) 
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 5.2.1 Age: time the recipient lived until the graft was implanted (expressed in 
years).  
 
 5.2.2 Sex: whether the recipient was male or female.  
 
5.2.3 Blood type: recipient blood group type out of the eight possible 
combinations. 
 
5.2.4 Hypertension: if the value of the recipient’s systolic blood pressure was 
superior or equal to 140 mmHg and/or diastolic pressure was superior or equal to 90 
mmHg before the surgical procedure.  
 
5.2.5 Diabetes mellitus: if the patient was diagnosed with diabetes before the 
date of the transplantation procedure.  
 
5.2.6 Body mass index: recipient’s body mass (expressed in Kg) over height 
(expressed in meters) squared.  
 
5.2.7 Time in waiting list: amount of time (in days) that each patient had to wait 
before the date of the procedure, after being introduced in the waiting list (a database 
that collects and orders by date of introduction of the information from the patients waiting 
to receive a kidney transplantation). The final order of patients receiving the kidney does 
not necessarily coincide with the order of waiting list because of compatibility and 
suitability issues.  
 
 5.2.8 Time in dialysis: amount of time that a patient spends in dialysis after being 
diagnosed with a chronic renal disease and until she or he undergoes the surgical 
procedure to receive a kidney, even if this one fails and the patient needs to go back to 
dialysis immediately after.  
 
 5.2.9 Number of previous transplants: for each patient, the number of kidney 
transplantation procedures that were performed prior to the date of the one described.  
 
 5.2.10 Race: a distinction was made between black and non-black recipients, as 
people of black race have been associated with lower graft survival. [26] In this program, 
no recipient was Black.  
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 5.2.11 Serum creatinine: as previously mentioned, creatinine is a waste product 
present in blood and excreted through urine. It is a good indicator of kidney function, as 
it is necessary for the calculation of the glomerular filtration rate, to estimate if kidneys 
are functioning correctly. Since patients are in dialysis before the transplant, creatinine 
values prior to the transplant date have no important meaning. Therefore, the creatinine 
values analyzed are those obtained after the procedure. More specifically, creatinine 
values were extracted for each patient at the date of hospital discharge, one month, six 
months, and every year after the surgery. All creatinine values for most of the patients 
were not available; for circumstances that are not under the hospital control, some 
recipients did not take the blood tests that they were recommended to take at the 
indicated dates, so there was missing information for the majority of them.  
  
It is important to note that because of the issue explained above, the only value 
that was available for all recipients was the one corresponding to the date of hospital 
discharge. Although that variable was not ideal for analysis, as it is not a fixed amount of 
time (while some patients were discharged some days after the procedure, for others it 
took several weeks to be sufficiently recovered to abandon the hospital facilities), it was 
the only one that could be used for all patients.   
 
 5.2.12 Glomerular filtration rate (GFR): amount of fluid filtered from the glomeruli 
per minute. The GFR value can give an estimation the optimal function of the implanted 
kidney. It was calculated for each creatinine value available and making use of the CDK-
EPI equation (see 5.1.9) 
 
 5.2.13 Transplantation date: date (day, month and year) in which the recipient 
underwent the operation. 
 
 5.2.14 Failure of the graft: if the transplanted kidney failed after the surgery. This 
failure can be classified as early (within one year of the surgery) or late (occurring after 
more than a year since the date of the procedure). There were 11 kidneys that failed out 
of the 100 that were analyzed, and among those 7 suffered from early failure, caused 
mainly by arterial/venous thrombosis or septic shock, and the other 4 suffered from late 
failure, due to acute rejection or advance chronic kidney disease. In those cases, besides 
looking at the reason of failure, the restarting date of dialysis was also obtained.  
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 5.2.15 Date of death: information regarding the date of death of the recipients 
that passed away since the start of the program in 2011 (a total of 7 individuals). There 
were no cases of death directly caused by the surgery of the transplants. 
 
 5.2.16 Cold ischemia time: amount of time that passes from the moment the 
organ is stored for preservation, after being extracted from the donor, to the moment it 
is transplanted in the recipient. Storing the organ in hypothermal conditions minimizes 
its energy requirements, and numerous studies have provided recommendations on the 
maximum number of hours that kidneys can be stored in such conditions in order not to 
decrease significantly its functionality, which is currently considered as 24h. [27] As it 
has been previously mentioned in section 3.3, the organ can suffer significant damage 
when stored and in the process of re-perfusion, and the total number of hours that it is 
preserve outside the body and the conditions in which such preservation occurs are of 
vital importance and need to be carefully examined.  
 
 5.2.17 HLA Compatibility: Human Leukocyte Agents (HLA) are proteins on the 
surface of white blood cells and other body tissues involved in immune recognition and 
able to identify foreign particles that could damage the body. So, the risk of acute 
rejection of the transplanted kidney is therefore affected by the disparity in these proteins 
between the donor and the recipient. HLA proteins can be divided in two main classes 
(class I and class II). Class I includes HLA-A, HLA-B and HLA-C, whereas class II 
contains HLA-DR, HLA-DQ and HLA-DP. A crossmatch test is necessary for all donors 
and recipients to avoid the possibility of graft rejection in the patient; however, the 
advancement in immunosuppressant drugs administered to the patients allows some 
degree of mismatching. [28] 
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6. DESCRIPTION OF THE DATA 
 
All the available analyzed data was obtained through access to the database of 
La Rioja Health Department, maintaining the privacy of each individual involved in the 
transplantation program. This extraction was tedious, as the information for each patient 
required to be searched and analyzed through the San Pedro Hospital information 
systems. It was required to spend at least 30 minutes to collect all the important 
information for each individual, and collaboration from the transplant coordinators - Dr. 
Martínez Soba and Dr. Calleja- was indispensable, not only to collect and help with 
guidance to learn how to navigate through the portal, but also to review the reports of 
some individuals and assess if any other medical conditions were important to mention.  
6.1 Description of recipients’ data 
 
As mentioned before, there were 100 procedures in the San Pedro Hospital 
between 2011 and September 2018, and out of those procedures, there were 98 
recipients – two patients received two kidneys, each at different procedures - and 100 
donors. In addition, 15 patients had already received one or more kidney transplants 
before the one received in this period of time (13 had received one transplant and 2 
people had received two). 
 
Some of the recipients were born in countries such as Pakistan, Argentina or 
Armenia, among others. In the following table the origin of the patients of each transplant 
is shown. It is important to keep in mind that the number of recipients from Spain and 
Brazil in the table is 85 and 2 respectively, since the nationality is computed for each 
transplant and disregarding the fact that there are two repeated patients; those two 
patients are originally from Spain and Brazil, so the actual number of patients born in 
those two countries would be 84 and 1. This issue affects as well the other variables 
discussed because the information for each transplant is analyzed individually and 
without considering that two patients had two implants.  
 
With respect to the sex of these recipients, 27% of the patients were females and 
73% were male, and the average age was 54.12. In this case, there were no important 
differences between the average age for the females (53.59), and the average age of 
the males (54.31). 
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TABLE 6.1. PLACE OF BIRTH OF THE 100 RECIPIENTS  
Place of birth Number of patients 
Spain 85 
Pakistan 5 
Argentina 2 
Brazil 2 
Armenia 1 
Colombia 1 
Italy 1 
Morocco 1 
Peru 1 
Rumania 1 
 
 The percentage of patients suffering from hypertension was of 95%, and 17 
recipients suffered from diabetes (3 had type II diabetes). The average waiting list time 
was 436.82 days, and it took on average 1676.6 days to receive the implant since the 
beginning of dialysis. In 24 out of the 100 surgeries the implanted kidney was the left 
one. 
 
TABLE 6.2 SUMMARY OF RECIPIENTS’ INFORMATION 
 
Sex 
Male: 73% 
Female: 27% 
 
Hypertension 
Yes: 95% 
No: 5% 
 
Diabetes Mellitus 
Type I: 14% 
Type II: 3% 
 
 
 
Blood Group 
(as indicated in the database) 
A 4% 
A+ 34% 
A- 6% 
B+ 3% 
B- 5% 
AB 1% 
AB+ 2% 
AB- 1% 
O 4% 
O+ 32% 
O- 8% 
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Average waiting list time  
436,82 days 
Average time since the beginning of dialysis 
until surgery 
1676.6 days 
 
Implanted kidney 
 
Left: 24% 
 
Right: 76% 
 
 
Regarding grafts survival, it is essential to mention that 11% implanted kidneys 
during the course of the program were non-functioning. There were different reasons 
why the kidney stopped functioning, and a distinction could be made between the ones 
that failed because of complications during surgery and those that failed because of the 
patient’s condition (an advanced chronic renal condition or an acute rejection of the 
implant).  
 
Out of the 11 implants that failed, 7 were caused by early surgical complications, 
while the other four were unsuccessful more than a year after the date of the operation. 
The personnel from the surgical team suffered changes and substitutions during these 
years, having a direct impact on the outcome of some transplants. Furthermore, it is 
important to keep in mind that the Hospital only received 100 organs in 7 years (a little 
bit more than 14 organs per year), so the inexperience of the team added to those 
changes in personnel seem a reasonable explanation for such situation. This number is 
expected to decrease in the future because of the experience that the surgeons are 
obtaining. 
 
During this time between 2011 and 2018, 8% of the recipients died, but no one 
did as a direct result of the surgical procedure. Though, it is worth mentioning that 5 out 
of those 8 patients passed away with a functioning implanted kidney; the rest passed 
away with non-functional kidneys.  
 
TABLE 6.3 TOTAL DEATHS OF RECIPIENTS BETWEEN 2011 AND 2018 
 
Total deaths = 8 
Deaths with functioning kidney = 5 
Deaths with non-functioning kidney = 3 
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6.2 Description of donor’s data  
 
There was a total of 100 different donors, coming from La Rioja, the Basque 
Country and other regions: Catalonia, Asturias, Cantabria, Madrid and Navarra. The 
accessibility to the donors data was still very restricted due to privacy issues, and all 
acquired information was obtained from the reports sent by the transplant coordination 
of the hospitals of origin to the San Pedro Hospital Transplant coordinators. These 
reports included information about the donor’s age, sex, blood group, hypertension, 
diabetes and creatinine levels before the extraction, as well as the origin of the implant, 
the cause of the death and the HLA compatibility matches.  
 
The average age of all donors was of 56.93 years. A differentiation could be made 
between the organs coming from La Rioja, Basque Country and other regions, resulting 
in average donor age of 59.76, 56.39 and 58.88 for each. 44 out of the 100 donors were 
females, 27% were hypertensive, and 8% were diabetic (no distinction between type I 
and type II was noted). Regarding the height and weight, the averages were 167.36 cm 
and 73.85 Kg, whereas the mean creatinine levels were 0.7505 mg/dl, inside the optimal 
range. At the national level, in 2017 60% of kidney donors were males, 20% were diabetic 
and 50% were hypertensive. [23] 
 
Fig. 6.1 Graft survival diagram from the 100 studied patients 
Deceased patients: 8% 
Functioning graft: 5% 
Non-functioning graft: 3% 
Alive patients: 92% 
Functioning graft: 84% 
Non-functioning graft: 8% 
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TABLE 6.4 NUMBER OF ORGANS FROM EACH REGION 
 
 
 
 
 
Another fundamental variable extracted was the cause of death. As previously 
discussed and explained, a classification was made to distinguish between heart beating 
or non- heart beating (asystole) deceased donors. In the San Pedro Hospital only type II 
and type III asystole are performed. 
 
The number of donors from brain death and asystole are shown in the following 
table. Brain death represented the 73.76% of total donor deceases in Spain in 2017.  
 
TABLE 6.5 NUMBER OF DONORS PER TYPE 
 
Brain death donors = 82 
 
 
Asystole donors = 18 
Type II asystole = 5 
Type III asystole = 13 
REGION OF ORIGIN CITY NUMBER OF 
ORGANS 
La Rioja Logroño 13 
Basque Country Barakaldo 22 
Bilbao 9 
San Sebastián 32 
Vitoria 14 
Galdakao 1 
Madrid Madrid 2 
Asturias Oviedo 2 
Cantabria Santander 2 
Catalonia Barcelona 1 
Badalona 1 
Navarra Pamplona 1 
 35 
 
TABLE 6.6 SUMMARY OF DONOR'S INFORMATION 
 
Other relevant collected information included the HLA compatibility mismatches 
and cold ischemia times for each organ. As it has already been explained, HLA 
compatibility is major factor to consider in order to avoid graft rejection and 
immunological responses. The following table shows the number of organs depending 
on the number of total mismatches between the donor and the recipient (HLA-A, HLA-B 
and HLA-DR have each two alleles, so the maximum global number of mismatches 
equals six). 
 
TABLE 6.7 NUMBER OF ORGANS ACCORDING TO THE GLOBAL NUMBER OF 
MISMATCHES 
 
 
 
 
 
 
 
 
 
 
 
Sex 
Male: 56% 
Female: 44% 
 
Hypertension 
Yes: 27% 
No: 73% 
 
Diabetes Mellitus 
Yes: 8% 
No: 92% 
 
 
 
Blood Group (as indicated in the reports) 
A+ 38% 
A- 8% 
B+ 3% 
B- 1% 
AB 1% 
O+ 39% 
O- 10% 
Average creatinine levels 0.7505 mg/dl 
Average height 167.36 cm 
Average weight 73.85 Kg 
Number of mismatches Number of organs with such 
number of mismatches 
0 1 
1 2 
2 11 
3 39 
4 34 
5 13 
6 0 
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The cold ischemia time measurement is essential to understand the state of the 
organ while stored and transported to La Rioja and its eventual function after 
implantation. The maximum number of hours that the organ should be stored is usually 
established at 48, but, as discussed, optimal maximum time is set at 24h [29]. It should 
be noted that there were seven organs that exceeded 24h of cold ischemia time, 50 
grafts experienced a cold ischemia time of 20 to 24 hours, and the other 43 kidneys had 
a cold ischemia time of 20 hours or less.  
 
For the analyzed 100 cases, the average cold ischemia time was 20.45 hours, 
and the median was 20.8 hours.  
 
TABLE 6.8 NUMBER OF ORGANS FOR EACH COLD ISCHEMIA TIME RANGE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cold ischemia time (hours) 
Number of organs with cold 
ischemia time in that range 
Ischemia >= 24 7 
20 < ischemia > 24 50 
Ischemia <= 20 43 
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7. ANALYSIS OF OUTCOMES 
 
To do all statistical analysis, some programming was required, and it was 
executed using the following software: The R Project for Statistical Analysis (R). 
7.1 Origin and distribution of the grafts 
The total number of recipients reviewed in the project equaled 100. Out of those 
100 patients, the organ that each patient received was obtained from one of the following 
hospitals:  
TABLE 7.1 REGION OF ORIGIN OF THE KIDNEYS 
 
Even though the program that started in 2011 implied a close collaboration 
between La Rioja and the Basque Country, some of the recipients received an organ 
originated in other regions.  Once a hospital is able to extract an organ from a donor, it 
is first offered to the region of that hospital or the region with which the hospital has an 
agreement, following the order of their waiting list. If in the region there is not a patient 
that can meet the compatibility or suitability requirements, the organ is offered to other 
REGION OF ORIGIN CITY HOSPITAL 
La Rioja Logroño Hospital San Pedro 
Basque Country Barakaldo Hospital Universitario de Cruces 
Bilbao Hospital Universitario Basurto 
 
San Sebastián Hospital Universitario Donostia 
Vitoria Hospital Santiago Apóstol 
Galdakao Hospital Universitario de Galdakao 
 
Madrid Madrid Hospital Universitario Doce de Octubre 
Hospital Universitario La Paz 
Asturias Oviedo Hospital Universitario Central de Asturias 
Cantabria Santander Hospital Universitario Marqués de Valdecilla 
 
Catalonia Barcelona Hospital Clinic de Barcelona 
Badalona Hospital Municipal de Badalona 
Navarra Pamplona Hospital de Navarra 
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locations where someone can receive it. This is the reason why some of the transplanted 
kidneys originated in more than the two regions (Basque Country and La Rioja) that 
participate in the collaborative program that is analyzed in this project. 
 
 For that reason, a distinction between the region of origin was made, so that the 
outcome of the transplants could be analyzed based on the location of extraction. The 
organs extracted in La Rioja were labeled as “1”, while the ones from the Basque Country 
were labeled as “2”. All other regions were grouped together as “3”.  
 
TABLE 7.2 CLASSIFICATION BASED ON THE REGION OF ORIGIN 
 
The program approved in 2011 between La Rioja and the Basque Country 
established a shared waiting list for both regions. Nevertheless, La Rioja is smaller in 
terms of population size and number of donors. So, the first required analysis was to 
prove that the distribution of the obtained kidneys was being fair for both regions. For 
that matter, current populations for both La Rioja and Basque Country were obtained 
from the internet [17]: 
 
 
REGION NUMBER REGION OF ORIGIN CITY 
1 La Rioja Logroño 
2 Basque Country Barakaldo 
Bilbao 
San Sebastián 
Vitoria 
Galdakao 
3 Madrid Madrid 
Asturias Oviedo 
Cantabria Santander 
Catalonia Barcelona 
Badalona 
Navarra Pamplona 
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TABLE 7.3 POPULATION OF LA RIOJA AND THE BASQUE COUNTRY 
REGION POPULATION 
LA RIOJA 315,794 
BASQUE COUNTRY 2,171,131 
 
The ratio of La Rioja population was then calculated: 
 
𝑅𝑎𝑡𝑖𝑜 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 =  
𝑅𝑖𝑜𝑗𝑎
𝑅𝑖𝑜𝑗𝑎 + 𝐵𝑎𝑠𝑞𝑢𝑒 𝐶𝑜𝑢𝑛𝑡𝑟𝑦
=  
315,794
315,794 + 2,171,131
= 0.127 
 
 
 
For the program, out of the 100 patients studied, the distribution according to 
the region of origin of the organ was as follows: 
 
TABLE 7.4 NUMBER OF ORGANS FOR EACH REGION NUMBER 
REGION OF ORIGIN REGION 
NUMBER 
RECIPIENTS (TOTAL = 100) 
LA RIOJA 1 13 
BASQUE COUNTRY 2 78 
OTHER 3 9 
 
Since the collaborative program was established between La Rioja and the 
Basque Country, those recipients who received a kidney from the region labeled as 
‘Other’ were disregarded for this analysis.   
  
The proportion of recipients of a kidney from La Rioja was then calculated: 
 
𝑃𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 =  
𝑅𝐿𝑅
𝑅𝐵𝐶 + 𝑅𝐿𝑅
=  
13
78 + 13
= 0.143 
   
 
After those calculations, a test of Test of Equal or Given Proportions was run on 
R, making use of the prop.test function. The Test of Proportions is used to analyze 
whether a certain population proportion equals another population proportion. [30] The 
RBC: Recipients of organ from the Basque Country        
RLR:  Recipients of organ from La Rioja 
Basque Country: population of Basque Country        
Rioja:  population of La Rioja 
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established null hypothesis is that both proportions are equal and the alternate 
hypothesis is that they are different. For a level of significance of 0.05, a p-value smaller 
than the level of significance would imply that the null hypothesis need to be rejected, 
and so, the two population proportions would be different. The obtained result is shown 
below: 
 
 Null hypothesis  H0: p1=p2     
 Alternate hypothesis  H1: p1p2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Before analyzing the results, it is important to define what the p-value is. The p-
value is the smallest level of significance for which the obtained sample would require 
rejecting the null hypothesis. It refers to the probability of obtaining a result that is less 
compatible with the null hypothesis than the result obtained with the sample. A p-value 
smaller than the fixed level of significance (in this project, always 0.05), implies lack of 
support to the null hypothesis (Ho), and so it must be rejected. A p-value larger than the 
fixed level of significance implies that support to the null hypothesis is enough not to 
reject it. [31] 
 
In this case, as the p-value equaled 0.8, we could not reject the null hypothesis, 
and therefore could not reject that the distribution of kidneys had been fair for both La 
Rioja and the Basque Country. It is important to mention that because the total number 
of organs was small, the 95% confidence interval obtained was very broad. 
 
Fig. 7.1 Proportion test for the populations and organ donation of La Rioja and 
the Basque Country 
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7.2 Analysis of the outcome of each transplant based on the origin of the graft 
 
In order to assess the success of the transplants, GFR was calculated for each 
patient, and the values were used to find possible relationships between success of the 
procedure and origin of the organ.  
 
7% of the implants did not correctly function as a consequence of the surgical 
procedure (because of intrarenal, arterial and venous thrombosis). Since the outcome of 
those grafts was directly affected by the operation, they were disregarded during the 
following analyses; the other 93 transplants were then the ones evaluated. 
 
The values of GFR were calculated following the CDK-EPI equation (5.1.9). This 
equation considers the age, sex, race and creatinine values for each patient. Race was 
disregarded for these calculations, as none of the patients analyzed were Black, and the 
creatinine value used corresponded to that of date of hospital discharge, since it is the 
only one that was available for all the studied individuals. After plotting the histogram, 
right skewness was observed, so natural logarithms were taken for normalizing the 
obtained data, as there is enough evidence to consider that the whole population follows 
a normal distribution, something that cannot be observed from the available data 
because there is still renal failure after the procedure in the vast majority of the cases. 
So, renal function was measured as the natural logarithm of GFR.  
 
A normal distribution can be defined as a continuous variable probability 
distribution that is used to represent random variables with unknown distribution. Its 
density function graph is a symmetric and bell-shaped curve, with height and width 
dependent on the population variance. The larger the variance (that is, the larger is the 
dispersion) the shorter and wider is the curve. [32] 
 
 In the case of the available data, values of Glomerular Filtration Rate could not 
be considered as a normal since most of patients had renal dysfunctions. However, it 
would have been a normal distribution if the totality of the population was considered. In 
order to perform test such as the Analysis of Variance (ANOVA), a normal distribution is 
a requirement, so the data needed to be normalized. [33] 
 
It has been previously mentioned that an optimal value of GFR was considered 
to be approximately 60 mL/min; however, this value needs to be put in context, as each 
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individual requires personal analysis. For instance, the optimal GFR value for a male 
with age bigger than 60 is different than the one for a 30-year-old male, and the optimal 
value of GFR for that 60-year-old male is different than the one for a 60-year-old female. 
In this case, for people that have recently undergone surgery to receive a kidney, a value 
of 60 mL/min is not common, especially at the date of hospital discharge. A positive 
evolution of the transplant would involve an increasing value of GFR over time, but this 
value may or may not rise above the 60 mL/min threshold even though the patient’s 
condition improves. 
 
 After taking natural logarithms, the following histogram was obtained: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Boxplots of the obtained date according to the region of origin were then 
represented, where region 1 corresponds to La Rioja, region 2 corresponds to the 
Basque Country and region 3 groups all other locations. 
 
 
 
log (60) = 4.09 
Fig. 7.2  Histogram for the logarithm of Glomerular Filtration Rate at the date of 
hospital discharge 
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At first glance, it could look like the kidneys from La Rioja (region 1) had higher 
value of GFR, and therefore better function. In order to assess the veracity of such 
statement, an ANOVA test was carried out.  
 
 The ANOVA (Analysis of Variance) test examines the possibility of having equal 
means for two or more populations. Nonetheless, certain conditions need to be satisfied 
in order to use it. Firstly, there has to be independence between the samples; secondly, 
data needs to present homoscedasticity (homogeneity of variance); and lastly, data 
needs to present normal distribution, which was not the case. It allows to compare 
different populations, establishing the null hypothesis that the populations are equal and 
the alternate hypothesis that at least one of them is different to the others. [34]  
 
 Null hypothesis  H0:  1=2=…=n   
 Alternate hypothesis  H1:  j=i   j =1, 2,…,n 
 
 Then, in order to normalize the data to perform the ANOVA test, a Box-Cox 
transformation was applied. The Box-Cox transformation consists on using a lambda 
value to transform the dependent variable (in our case the GFR at the time of hospital 
discharge) to obtain a linear model.  
 
The Box-Cox transformation can be completely defined as a power 
transformation used to transform non-normally distributed dependent variables into a 
(7.1) 
Fig. 7.3 Boxplots of the log(GFR) at the date of hospital discharge according to the region 
of origin 
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normally distributed set. To do so, a lambda (𝜆) value is calculated and used to calculate 
the new values of the variable. The lambda value is obtained with a log-likelihood 
procedure. [35] 
𝑋. 𝑛𝑒𝑤 =  
(𝑋. 𝑜𝑙𝑑𝜆 − 1)
𝜆
 
 
This is the code used to extract the boxplots for the transformed data according 
to the region of origin: 
 
Obtaining the following figure: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.4 Script used for data transformation 
Fig. 7.5 Boxplots of transformed GFR at the date of hospital discharge according to 
the region of origin 
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Once the data was normalized, the ANOVA test was run with the following piece of code: 
 
 
 
 
 
 
 
As the p-value obtained equaled 0.11 (bigger than 0.05), it could not be 
concluded that there were significant differences between the GFR means of the three 
populations. 
 
 
7.3 Analysis of the outcome of each transplant based on the distance of the hospital 
of origin to Logroño 
 
Even though the analysis by regions was found to be non-significant, a more in-
depth analysis was required. The objective in this case was to analyze the functionality 
of the transplanted kidneys (again, using the GFR value at the date of hospital discharge) 
against the distance that the graft traveled before being implanted in the recipient.  
  
To do so, the first step consisted on finding on the internet the distances from 
each of the hospitals to the San Pedro Hospital, where the transplantation procedures 
always took place. The Google Maps tool was used [36], and road distances were 
considered.  
 
The following table was created: 
 
 
 
 
Fig. 7.6 Script and result obtained for the ANOVA test 
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 TABLE 7.5 DISTANCE FROM THE HOSPITAL OF ORIGIN TO THE SAN PEDRO HOSPITAL 
 
 
Data was then normalized, using the Box-Cox transformation, and a linear 
regression was calculated with R. A linear regression model tries to model a relationship 
between two variables. To do so, the studied data is fitted into a linear equation:  
 
𝑦 = 𝑎 + 𝑏𝑥 
 
In such equation, the variable x is considered the explanatory variable, while the 
variable y is the dependent variable. Constant a represents the intercept with the y axis, 
and b is the value of the slope of the line. [37] 
 
Once a linear regression is applied, the p-value (probability value) indicates the 
level of significance of the model. A p-value smaller than 0.05 would indicate that there 
is a significant relationship between the explanatory and the dependent variables. 
 
CITY HOSPITAL DISTANCE TO SAN PEDRO 
HOSPITAL (km) 
Logroño Hospital San Pedro 0 
Barakaldo Hospital Universitario de Cruces 144 
Bilbao Hospital Universitario Basurto 139 
San Sebastián Hospital Universitario Donostia 164 
Vitoria Hospital Santiago Apóstol 68 
Galdakao Hospital Universitario de Galdakao 
 
139 
Madrid Hospital Universitario Doce de Octubre 331 
Hospital Universitario La Paz 327 
Oviedo Hospital Universitario Central de Asturias 420 
Santander Hospital Universitario Marqués 
de Valdecilla 
234 
Barcelona Hospital Clinic de Barcelona 470 
Badalona Hospital Municipal de Badalona 482 
Pamplona Hospital de Navarra 51 
(7.2) 
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To check that the data was correctly transformed and that it followed a normal 
distribution after applying the Cox-Box transformation, the residuals’ histogram was 
reviewed. A residual can be defined as the difference between the observed and the 
predicted value for each point, and the histogram of the residuals for a linear regression 
model should show a normal distribution to assess the normalization of the data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The result of the regression can be observed in the following figure: 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.7 Graph representing GFR at the date of discharge depending on the distance 
from the origin of the organ to San Pedro Hospital 
Fig. 7.8 Linear regression model for the normalized GFR and the distance to San Pedro Hospital 
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As it can be observed, the p-value obtained equaled 0.197, so it could not be 
concluded that there was a significant relationship between distance and organ function. 
The conclusion was not exactly the same when the analysis was conducted exclusively 
for the two participating regions in the collaborative program (in that case, p-value 
obtained was 0.0716). That p-value was not smaller than 0.05, so no strict relationship 
could be established, but it was closer than the previous one, which would indicate that 
the organs whose origin was the Basque Country had worse outcomes at the time of 
hospital discharge than those from La Rioja.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.9 Linear regression model for the normalized GFR and the distance to San Pedro Hospital, only 
considering the regions of La Rioja and the Basque Country 
 
7.4 Analysis of the outcome of each transplant based on KDRI 
 
In the year 2009, professors from the University of Michigan and Ohio State 
University elaborated an index to assess the life expectancy of deceased donor kidneys, 
the Kidney Donor Risk Index (KDRI). [38] The objective of the KDRI is to estimate 
quantitatively the survival time of kidneys based exclusively on donor and transplant 
parameters.  
 
Using data obtained from the Scientific Registry of Transplant Recipients and 
analyzing the importance of different donor parameters, the researchers developed a 
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prediction equation able to give an estimated value of graft survival (the lower the value 
of the KDRI obtained, the higher the expected survival of the graft).  
 
The donor parameters taken into account for such prediction equation were the 
following: age, height, weight, race of the donor, creatinine value before the organ 
extraction, hypertension, diabetes or presence of Hepatitis C virus in the donor, and the 
cause of death (cerebrovascular accident or donation after cardiac death); on the other 
hand, the transplant parameters analyzed were: HLA mismatches between donor and 
recipient (HLA-B and HLA-DR) and cold ischemia time for each transplant. In addition, 
the equation includes information regarding the number of organs involved in the 
transplantation (block transplantation or double kidney transplant), which are not 
considered in this case, since none of the patients were transplanted from the program 
in such conditions.  
 
For the analysis, a reference donor was established. This reference donor was a 
40-year-old non-African race person, with a height of 170 cm, weight of 80 kg, non-
diabetic, non-hypertensive brain dead donor with hepatitis C virus negative, and with a 
serum creatinine of 1 mg/dL; in addition, two HLA-B mismatches and one HLA-DR 
mismatches were considered, as well as a cold ischemia time of 20 hours.  
 
The resulting KDRI prediction equation was:  
 
 
  
 
 
 
 
 
 
 
Making use of this equation and the available donor data, a linear regression 
model was calculated to check for a possible relationship between GFR and KDRI 
values. This could imply that the Kidney Donor Risk Index can be applied to our data as 
a predictor of kidney function post-transplantation.  
 
(7.3) 
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The Box-Cox transformation model was again used to normalize the data and the 
regression model was created: 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.10 Linear regression model for the normalized GFR and Kidney Donor Risk Index 
(KDRI) 
The p-value obtained in this case equaled 0.0678. This value would technically 
implicate that there is no significant relationship between the GFR and KDRI variables 
(as p-value > 0.05). However, it is worth mentioning that it is located near the edge of 
being significant. Therefore, it could be assumed that the KDRI can be an indicator of 
good organ function for the analyzed data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.11 Linear regression model graph for normalized GFR and KDRI 
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To continue, a similar examination was made but using two explanatory variables 
(KDRI and Distance). The normalization was made using the Box-Cox transformation, 
but considering the two explanatory variables, and they were included as well in the 
regression model.  
 
Fig. 7.12 Linear regression model for the normalized GFR and two explanatory variables (KDRI 
and distance to San Pedro Hospital) 
 
The joint p-value obtained (0.0915) revealed no relevant significance, and it could 
be observed directly the importance of the Kidney Donor Risk Index over the Distance. 
 
 
7.5 Analysis of the outcome of each transplant based on cold ischemia time 
 
Cold ischemia time can be defined as the number of hours that passes since the 
kidney is preserved to the moment it is transplanted on the recipient. Information on the 
cold ischemia time preceding the transplantation procedure was collected by the 
Transplant Coordination of La Rioja at the San Pedro Hospital, and was provided for 
analysis.  
 
The aim in this case was to find a possible relationship between the GFR value 
at the date of hospital discharge and cold ischemia time. The Box-Cox transformation 
was utilized to normalized the available date, and the regression model was calculated: 
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Fig. 7.13 Linear regression model for the normalized GFR and cold ischemia time 
 
The p-value (0.00198 < 0.05) indicated a significant relationship between GFR 
and cold ischemia time. A longer preservation of the organ therefore implied a lower GFR 
value at the time of hospital discharge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.14 Linear regression model graph for the normalized GFR and cold ischemia time 
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From this evaluation, it could be extracted that conservation is a key factor to take 
into account, as cold ischemia time could be interpreted as a predictor of the immediate 
success of the transplant. Nevertheless, it is important to keep in mind that the GFR 
value analyzed was the one at the date of hospital discharge, so a lower GFR value at 
this point does not necessarily imply better performance in the long term.  
 
Moreover, distance could not be considered a predictor of the success because 
the cold ischemia time for longer distances was found to be smaller. This is due to the 
fact that the transportation of organs from farther regions is usually completed by plane, 
reducing the time that the organ remains preserved in the fridge. For instance, the cold 
ischemia time of the organ transported from Barcelona was found to be shorter (14.6 
hours) than all the ones from originated in Vitoria, even though the distance from 
Catalonia to Logroño is much greater.  
 
Furthermore, the San Pedro Hospital in Logroño lacks resources to proceed with 
the operation at any time of the day, leading to more cold ischemia hours in case an 
organ becomes available during the night, since the procedure would take place on the 
following morning. 
 
Finally, it is important to mention that the KDRI equation considers the value of 
cold ischemia time for the calculation of the Kidney Donor Risk Index. Since cold 
ischemia time and GFR were found to have a significant connection, a relation between 
KDRI and GFR can also be established. 
 
In conclusion, La Rioja and the Basque Country need to reduce cold ischemia 
times of the organs to improve the functionality of those kidneys once they are 
transplanted.  
 
7.6 Variation of time of ischemia and GFR depending on the season 
 
The way the organ is transported has a direct effect on the outcome of the 
transplant, so in order to additionally evaluate the importance of cold ischemia time and 
the transportation conditions, data was separated into two categories. This was 
performed with the intention of finding other variables that may affect kidney function 
through the process. 
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For that matter patients were separated into two groups: those who received an 
organ in April, May, June, July, August or September, and those who received it in either 
October, November, December, January, February or March.  
 
The separation was made based on climatological conditions, as the average 
temperature in Spain from April to September can be considered as different than the 
average temperature from October to March, and external environmental conditions can 
affect the general temperature of the fridge that transports the organ (hotter seasons 
could raise the temperature above the recommended limits, damaging the organs). 
 
After creating the dichotomous variable Season and assigning a value of 1 to the 
organs transported from October to March -the cold season-, and a value of 2 to those 
transported from April to September - the hot season-, normalization was applied using 
the Box-Cox transformation.  
 
The main purpose was to analyze the possible differences of GFR at the date of 
discharge (that is, kidney function) depending on the season in which the transplant took 
place. Boxplots were represented for the GFR values corresponding to each season, 
and a t-test was to compare the means of the two variables was run as follows: 
 
Null hypothesis  H0:  cold =  hot    
 Alternate hypothesis  H1:  cold  hot 
 
 
 
 
 
 
 
 
 
Fig. 7.15 Boxplots of transformed GFR at the date of hospital discharge 
according to the season 
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Fig. 7.16 T-test script to compare GFR means during hot and cold seasons 
 
The p-value obtained (0.2) indicated that it could not be concluded that there 
were significant differences in the GFR value depending on the season in which the 
procedure took place.  
 
In order to analyze the part of the GFR value at the time of discharge that is not 
explained by the cold ischemia time, the residuals from the GFR ~ ischemia linear model 
previously created were considered (Fig. 7.13). The aim was to check any difference in 
the quality of the transplanted organs depending on the season when they were 
transplanted, but considering equal cold ischemia times for all of them so that it does not 
influence the obtained results. 
 
Boxplots were represented as well for these residuals, corresponding to each 
season, and a t-test was to compare the means of the two residual variables was 
evaluated: 
 
Null hypothesis  H0:   ResidualsCold =   ResidualsHot  
 Alternate hypothesis  H1:   ResidualsCold   ResidualsHot 
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Fig. 7.17 Boxplots of transformed GFR residuals at the date of hospital discharge according to the season 
 
 
 
 
 
 
 
 
 
Fig. 7.18 T-test script to compare GFR residuals means during hot and cold seasons 
 
In this case a p-value of 0.3 was observed, so it could not be concluded that there 
were significant differences in the procedures depending on the season, especially now 
that the effects of the cold ischemia times were not taken into account. 
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8. ANALYSIS OF STORAGE CONDITIONS. EXPERIMENT 
 
To continue with the investigation of the conditions of the organs during the 
transportation to the San Pedro Hospital in Logroño, it was required to check not only 
the external climatological conditions, but also the internal ones in the fridge that contains 
the organs. For that purpose, it was important to collect data regarding the temperature 
inside the container to confirm that the kidneys were being carried at the appropriate and 
recommended range of temperatures.  
 
As it has been previously mentioned, the technique to store each kidney is 
standardized by the National Transplant Organization for all Spanish regions, and 
involves covering the organ with several layers of bags, with preservation solutions, and 
a container, surrounded by ice and located inside a conventional fridge, without any 
motors. This method has a lot advantages, as it is simple and inexpensive, but lacks 
reliability during the transport as there are no additional instruments to monitor the 
temperature at every moment to ensure that the organ is stored at the appropriate 
temperature range (4-5ºC, never below 0ºC to avoid freezing, and never above 5ºC to 
minimize energy consumption). Even though the method is efficiently designed and 
appropriately tested, its lack of complexity did not allow to record information on the 
temperature of each organ that was transplanted to the receptors in La Rioja.  
 
Since no information was available for analysis for the studied cases, a simple 
experiment was design to test that the temperature conditions were maintained using 
this packaging method, which consisted on placing a portable thermometer inside the 
‘Duchess’ and monitor for several hours the temperature inside the container, simulating 
the conditions that any other kidney ready to be transplanted would have. To carry out 
this experiment the Transplant Coordination Unit of La Rioja, politely and following all 
legal requirements, asked families if they would accept to donate the kidneys of their 
deceased relatives for experimental purposes, even if that organ was not in good 
condition to be donated for transplantation. Those organs were then extracted and stored 
reproducing the real situation. 
 
To measure the temperature inside the ‘Duchess’, different possibilities were 
considered to ensure that certain conditions were satisfied, such as having a device that 
could be as close as possible to the organ but without incurring in damage to it, 
waterproof, small enough to fit into the container and that could be monitored from the 
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outside. The solution found was to use a RFID (radio frequency identification) 
temperature sensor, and given the time constraints to carry out the experiment - as the 
number of available organs donated for study is low-, the best available devices in the 
market were searched, and the model LOM16 from the company NEWSTEO Wireless 
Monitoring was selected, with the following characteristics [39]: 
 
 
TABLE 8.1 NEWSTEO WIRELESS MONITORING LOM 16 DEVICE. 
TECHNICAL CHARACTERISTICS 
Size 90mm x 26mm 
Weight 26 g (with battery) 
Operating temperature range -40°C … +70°C 
 
Accuracy ± 0.3°C [‐30°C…+60°C], ± 1°C beyond 
 
Resolution 0.1°C 
 
Measurement frequency From 1 measurement per second to 1 measurement 
every 4 hours 
Memory capacity Up to 32 256 measurements with date and time 
 
Signal range in free field Up to 200 m 
Battery 1/2 AA Lithium Thyionle with connector 
 
 
Along with the two LOM 16 sensors purchased, an antenna to receive the signals 
and a software to automatically collect and write the data into a computer were also 
included. 
 
 
 
 
 
 
 
 
  
Fig. 8.1 Materials used: LOM16 RFID sensor, key 
containing the required software for visualization and 
receptor antenna 
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The working mechanism of the experiment consisted on introducing one of the 
tube-shaped sensors inside a plastic bag, and introducing this bag inside the ‘Duchess’ 
and near to the organ, as close as possible but in a way that no damage could not be 
done to the kidney, even if this one was not going to be used for transplantation 
purposes. The sensor emitted a radiofrequency that was detected from the outside. The 
same procedure was applied with another sensor, which was in this case on the outside 
of the ‘Duchess’ but inside the fridge, where the ice is usually located.  The aim was to 
detect both temperatures and analyze the differences for each of the experiments carried 
out with every organ.  
 
A total of four kidneys were donated for the experiment, and the temperature data 
was collected every 2 minutes. The graph was automatically drawn for each case as 
well.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preservation liquid 
B
ag
 
B
ag
 
‘Duchess’ 
 
Fridge 
Saline solution 
Fig. 8.2 Schematics of the working mechanism 
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Below are examples of two of the obtained graphs: 
 
Fig. 8.3 Graphs obtained for the experiments carried out, using two temperature sensors, placed inside 
and outside the ‘Duchess’ 
 
As it can be observed, the graphs showed that the temperature is not preserved 
accurately in the optimal temperature range (ideally 4-5ºC). In contrast, the results 
showed acceptable, but no great, preservation temperatures between 0ºC and 5ºC, and 
in some cases alarming temperatures below 0ºC that could cause the organ to freeze.  
 
Although economic and easy to prepare, the storage method was detected to be 
imprecise. Further and more in-depth analysis will be required to design a better storage 
technique that can maintain the low-cost and ease of this system.  
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9. CONCLUSIONS 
 
The renal transplantation program initiated in the year 2011 between La Rioja 
and the Basque Country has been a success in terms coordination, reducing waiting lists 
and making donation and transplantation available for a wider population. Despite this 
accomplishment, that has positioned both La Rioja and the Basque Country on top of 
the regions with higher donation and transplantation rates in Spain, the analysis 
presented in this report shows room for enhancement.   
 
In order to improve the glomerular filtration rate value of the patients at the date 
of hospital discharge, both communities need to work towards reducing cold ischemia 
times, as longer cold ischemia times have been shown to decrease the functionality of 
the organs when patients leave the hospital facilities. In addition, efforts need to be 
placed on improving the storage conditions of the organs to maintain the kidneys in the 
optimal temperature range, as the current method has been proven to lack precision in 
that sense.  
 
Lastly, it is important to understand the small amount of operations carried out in 
the San Pedro Hospital every year when compared to other national hospitals. In that 
regard, surgeons had less patients to operate and to gain experience, so the learning 
curve is expected to increase over the future years, which could help avoid some of the 
early graft failures that took place. 
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10. SOCIO-ECONOMIC IMPACT 
10.1 Research impact 
 
The success Spain has achieved throughout these years regarding transplant 
coordination, donation and transplantation has been astonishing, becoming an 
international benchmark and leader in the field. Nonetheless, the National Transplant 
Organization is continuously examining ways to improve the system even more, and the 
report here presented aims to contribute to that objective.  
 
Primarily, it is important to mention that it is not common in Spain to complete the 
analysis performed in this report. Most of the Autonomous Communities do not share 
the data as in this case, and the fact that this could be done here, with the help of the 
Transplant Coordination Unit of La Rioja, could stimulate the rest of the Transplant 
Coordination Units to contribute and aid improving the tremendously efficient system we 
are fortunate to have in our country.  
 
This project has the ultimate intention of improving the outcomes of patients 
receiving kidney transplants, and it has been concluded that there are indeed some 
variables, which could be controlled, that can help for that purpose. The analysis 
accomplished can therefore have high social implications in the area, especially for those 
in need of a renal transplant in the future. 
 
Finally, it is worth mentioning how surprising it is for an impressively developed 
system to keep transporting the organs in such a rudimentary manner. This report could 
therefore have implications in suggesting the research of other ways that could transport 
the organs in perfect conditions, as their state is fundamental for the result of the 
procedures. 
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10.2 Project costs 
 The table below summarizes the items used and its costs for the project, along 
with the costs of personnel and the number of hours that each of them contributed to this 
activity. 
TABLE 10.1 PROJECT COSTS 
 
TABLE 10.2 PERSONNEL COSTS 
 
 
 
  
PROJECT COSTS 
  
 
Item 
 
# Units 
 
Cost per unit (€) 
 
Total cost (€) 
 
Refrigerators 
 
2 
 
75 
 
150 
 
Ice (bags of 3 kg) 
 
10 
 
2 
 
20 
 
NEWSTEO Wireless 
Monitoring LOM16 
(2 loggers, software, 
magnet, batteries) 
 
1 
 
350 
 
350 
 
Personal computer 
1 800 800 
 
R project software 
1 Free - 
 
Other software 
1 100 100 
 
Round bus trips from 
Madrid to Logroño 
 
10 
 
30 
 
300 
                                                                                          Subtotal:                1,720€ 
  
PERSONNEL COSTS 
  
 
Subject 
 
# Hours 
 
Cost per hour (€) 
 
Total cost (€) 
 
Student 
 
360 (12 ECTS) 
 
20 
 
7,200 
 
Tutors 
 
100 
 
45 
 
4,500 
 
Surgeons 
 
50 
 
60 
 
3,000 
 
Nurses 
 
50 
 
35 
 
1,750 
                                                                                        Subtotal:                16,450€ 
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Then, the approximated total cost was:  
 
TABLE 10.3 TOTAL PROJECT COSTS 
 
 
 
 
Below is a table with the estimated cost of each of the 100 transplants studied 
in this project, including the procedure, medication and treatment: 
 
 
TABLE 10.4 ESTIMATED TRANSPLANT COSTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCEPT 
 
TOTAL COST 
 
PROJECT 
 
1,720 € 
 
PERSONNEL 
 
16,450 € 
 
18,170 € 
  
TRANSPLANT COSTS 
 
 
# Transplants 
 
Estimated cost per 
transplant (€) 
 
Total cost (€) 
 
100 
 
32,000 
 
3,200,000 
                                                            Subtotal:            3,200,000 € 
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Intensiva, 2009.  
[14]  Hospital San Pedro. Coordinación de Trasplantes, "PROTOLOCO DE 
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